ERBB2 and breast cancer: First, although 86 BC specimens were enrolled in our study, it finally included only 45 HER2-positive, 35 CK5/6-positive, and 40 ER-positive cases, which could result in possible sample selection bias and would have been more justifiable with more subjects.